ARK Space & Defense Innovation ETF vs Oscar Health Inc — how do they compare? ARK Space & Defense Innovation ETF trades at $34.69, while Oscar Health Inc trades at $28.84 (market cap $8.63B). Which is the better fit depends on your goals.
| ARKX | OSCR | |
|---|---|---|
Sector | Sector/Thematic | Health |
52-Week High | $37.74 | $32.18 |
52-Week Low | $25.46 | $10.85 |
Market Cap | — | $8.63B |
Enterprise Value | — | $4.99B |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
OSCR trades at $27.97, up 1.08% today, with a bearish technical signal but strong recent earnings beats in Q1 and Q2 2026. The company reported record profitability and raised its full-year outlook, driven by membership growth and cost controls. Key support lies at $26, with resistance at $28. Revenue surged 70% year-over-year in H1 2026 to $4.9 billion, per PYMNTS on August 6, 2026.
Outlook is positive due to robust growth and margin expansion, but risks include execution challenges and competitive pressures. Analysts have a consensus price target of $32.50, with 27% buy ratings. The stock offers value with a P/S of 0.53, though net income volatility remains a concern.
Trailing returns across standard periods
ARKX is an actively managed ETF that invests in companies leading space exploration and defense innovation. It focuses on orbital and sub-orbital aerospace, reusable rockets, and enabling technologies like AI, robotics, and satellite systems.
Read more on ARKX →Oscar Health, Inc. is a health insurance company that utilizes a technology-driven approach to simplify the healthcare experience. The company offers individual, small-group, and Medicare Advantage plans, primarily through a platform that integrates technology, data, and design to provide members with a personalized, efficient healthcare journey. Oscar aims to lower costs and improve engagement by focusing on consumer-centricity and modernizing the traditional health insurance model.
Read more on OSCR →